About Complete Genomics
Complete Genomics is a company based in San Jose (United States) founded in 2006 by Radoje Drmanac was acquired by Huada Gene in September 2012.. Complete Genomics has raised $124.99 million across 4 funding rounds from investors including Huada Gene, Orbimed and Prospect Venture Partners. Complete Genomics offers products and services including DNBSEQ™ Technology, Kits & Reagents, and Sequencing Platforms. Complete Genomics operates in a competitive market with competitors including Nanopore, Cepheid, PacBio, Omniome and QuantuMDx, among others.
- Headquarter San Jose, United States
- Founders Radoje Drmanac
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Complete Genomics Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$124.99 M (USD)
in 4 rounds
-
Latest Funding Round
$39 M (USD), Series E
Aug 19, 2010
-
Investors
Huada Gene
& 7 more
-
Employee Count
Employee Count
-
Acquired by
Huada Gene
(Sep 17, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Complete Genomics
Complete Genomics offers a comprehensive portfolio of products and services, including DNBSEQ™ Technology, Kits & Reagents, and Sequencing Platforms. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Delivers accurate PCR-free NGS for genomics research applications.
Facilitates sample extraction and library preparation for sequencing.
Provides fast data for WGS and spatial omics analysis.
Funding Insights of Complete Genomics
Complete Genomics has successfully raised a total of $124.99M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $39 million completed in August 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series E — $39.0M
-
First Round
First Round
(31 Mar 2008)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2010 | Amount | Series E - Complete Genomics | Valuation | Sands Capital Management | |
| Aug, 2009 | Amount | Series D - Complete Genomics | Valuation | Orbimed , EW Healthcare Partners | |
| Jul, 2009 | Amount | Series C - Complete Genomics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Complete Genomics
Complete Genomics has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Huada Gene, Orbimed and Prospect Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in US life sciences and healthtech firms.
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Venture capital investment and entrepreneur support services.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Complete Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Complete Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Complete Genomics Comparisons
Competitors of Complete Genomics
Complete Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, Cepheid, PacBio, Omniome and QuantuMDx, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| domain | founded_year | HQ Location |
Developer of molecular diagnostic testing solutions
|
|
| domain | founded_year | HQ Location |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| domain | founded_year | HQ Location |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| domain | founded_year | HQ Location |
Handheld diagnostic and sequencing devices are developed for personalized healthcare.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Complete Genomics
Frequently Asked Questions about Complete Genomics
When was Complete Genomics founded?
Complete Genomics was founded in 2006 and raised its 1st funding round 2 years after it was founded.
Where is Complete Genomics located?
Complete Genomics is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Is Complete Genomics a funded company?
Complete Genomics is a funded company, having raised a total of $124.99M across 4 funding rounds to date. The company's 1st funding round was a Series C of $14.49M, raised on Mar 31, 2008.
What does Complete Genomics do?
Complete Genomics was founded in 2006 in San Jose, United States, within the biotechnology sector focused on genomics. A proprietary DNA nanoball sequencing technology is utilized to create the Revolocity Platform, which supports whole genome and exome sequencing with fragment lengths of 250-500 bp. Analysis algorithms and data management software are provided for variant reports and assemblies, enabling research operations in human DNA sequencing.
Who are the top competitors of Complete Genomics?
What products or services does Complete Genomics offer?
Complete Genomics offers DNBSEQ™ Technology, Kits & Reagents, and Sequencing Platforms.
Who are Complete Genomics's investors?
Complete Genomics has 8 investors. Key investors include Huada Gene, Orbimed, Prospect Venture Partners, Highland Capital Partners, and Enterprise Partners Venture Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.